I-Flow welcomes AcryMed as 2007 growth exceeds forecasts
This article was originally published in Clinica
Executive Summary
I-Flow, the Lake Forest, California-based manufacturer of pain management systems, said total sales for 2007 outpaced its expectations by increasing 24% to $116.5m. The company had previously forecast annual sales growth to be 20%. Sales of its regional anaesthesia products, which provide site-specific pain management, were also better than expected, growing 32% to $89.6m. In conjunction with its preliminary 2007 results, the firm announced the closing of its acquisition of AcryMed. I-Flow inked a $25m all-cash deal to buy the Beaverton, Oregon-based developer of silver-based infection control and wound healing technologies in December 2007 (see Clinica No 1287, p 12).
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.